Replies to post #224907 on Biotech Values

[DewDiligence]

ICPT prices $460M* stock-and-convertible-debt offering:

https://www.globenewswire.com/news-release/2019/05/10/1821822/0/en/Intercept-Pharmaceuticals-Announces-Pricing-of-Offerings-of-Common-Stock-and-Convertible-Senior-Notes-due-2026.html

The stock portion of the offering is at $83.50—a 5% discount to Wednesday’s close.

*Assuming exercise of underwriter’s option.